Special Drug-Use Surveillance Study on Vedolizumab for IV Infusion 300 mg [Ulcerative Colitis]

A Study to Assess Clinical Effectiveness and Safety of Vedolizumab Intravenous in Real World Clinical Practice in Ulcerative Colitis (UC) Korean Participants

NCT03535649 ·Status: COMPLETED

Entyvio (Vedolizumab) Long Term Safety Study

NCT02674308 ·Status: COMPLETED

A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease

NCT02620046 ·Status: COMPLETED ·Phase: PHASE3

An Observational Follow-up Study for Subjects Receiving Salvage Therapy After Previous Treatment in a Visilizumab Study for Intravenous Steroid-Refractory Ulcerative Colitis

NCT00355901 ·Status: TERMINATED

EFFICACI : EFFicacy of Intravenous Infliximab Versus Vedolizumab After Failure of subCutaneous Anti-TNF in Patients With UlCerative Colitis

NCT03679546 ·Status: COMPLETED ·Phase: PHASE4

Vedolizumab Subcutaneous (SC) Versus Intravenous (IV) in Ulcerative Colitis or Crohn's Disease

NCT02913508 ·Status: WITHDRAWN ·Phase: PHASE2

A Study of Intravenous Vedolizumab Administered Every 4 Weeks in Japanese Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease

NCT04738942 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Phase III Study of MLN0002 (300 mg) in the Treatment of Ulcerative Colitis

NCT02039505 ·Status: COMPLETED ·Phase: PHASE3

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

NCT06095128 ·Status: RECRUITING ·Phase: PHASE4

Measuring Endoscopic ACTIvity in Patients Treated With VEDOlizumab for Ulcerative Colitis

NCT03839680 ·Status: UNKNOWN

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in Real-World Practice

NCT04890262 ·Status: COMPLETED

Efficacy and Safety of Vedolizumab Combined With Upadacitinib in Patients With Ulcerative Colitis

NCT06095596 ·Status: RECRUITING ·Phase: NA

A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting

NCT06581328 ·Status: RECRUITING ·Phase: PHASE4

A Study of Kynteles Injection (Vedolizumab) in Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease or Chronic Pouchitis

NCT04799496 ·Status: COMPLETED

A Study of Vedolizumab in Adults in Real-World Practice

NCT04872491 ·Status: COMPLETED

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of UTTR1147A Compared With Placebo and With Vedolizumab in Participants With Moderate to Severe Ulcerative Colitis (UC)

NCT03558152 ·Status: COMPLETED ·Phase: PHASE2

Value of Pharmacokinetic Assays in the Prediction of Therapeutic Response in Ulcerative Colitis

NCT03724929 ·Status: TERMINATED ·Phase: NA

A Study to Determine the Pharmacokinetics (PK) of Single Intravenous (IV) Dose of Vedolizumab 300 Milligram (mg) in Healthy Adult Chinese Participants

NCT03329209 ·Status: COMPLETED ·Phase: PHASE1

Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease

NCT02425111 ·Status: COMPLETED ·Phase: PHASE3

Evaluating the Shift From Intravenous to Subcutaneous Vedolizumab for Inflammatory Bowel Disease

NCT07123350 ·Status: ACTIVE_NOT_RECRUITING

An Open Label Phase 4 Study to Evaluate Efficacy of Early Versus Late Use of Vedolizumab in Ulcerative Colitis

NCT02646657 ·Status: COMPLETED ·Phase: PHASE4

A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Practice in Switzerland

NCT04989907 ·Status: COMPLETED

Subcutaneous Interval Lengthening of Vedolizumab for Economic Research

NCT06584162 ·Status: RECRUITING ·Phase: PHASE4

Study to Evaluate the Safety and Efficacy of Two Adalimumab Dosing Regimens in Subjects With Moderate to Severe Ulcerative Colitis

NCT02065622 ·Status: COMPLETED ·Phase: PHASE3

A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Practice in Poland

NCT05384080 ·Status: COMPLETED